A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD) - DUPLEX-AD - Janssen Research & Development, LLCSee more
Hidradenitis suppurativa
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa - RECHARGE 1 - Novartis PharmaceuticalsSee more
